Medicure Inc.
OTC: MCUJF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Albert David Friesen
- Employees
- 23
- Headquarters
- Winnipeg, Canada
- IPO year
- 2004
- Market cap
- $7.0M
- Website
- https://www.medicure.com
Loading MCUJF…
Loading profile data…Frequently asked questions about MCUJF
What does Medicure Inc. (MCUJF) do?
Medicure Inc. operates as a biopharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for the cardiovascular market, primarily serving Canada and the United States. Among its key offerings is AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist specifically designed to manage...
Where does MCUJF trade?
Medicure Inc. (MCUJF) trades on the Other OTC.
What sector is MCUJF in?
Medicure Inc. (MCUJF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Medicure Inc.?
Albert David Friesen is the chief executive officer of Medicure Inc. (MCUJF).
Where is Medicure Inc. headquartered?
Medicure Inc. is headquartered in Canada.
Does MCUJF pay a dividend?
Medicure Inc. (MCUJF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MCUJF go public?
Medicure Inc. (MCUJF) completed its initial public offering in 2004.